Download pdf - EDITORIAL COMMENT

Transcript
Page 1: EDITORIAL COMMENT

tumor bed and resection rim, frozen section analysis, biopsyof the peripheral parenchyma, postoperative radiation of theremaining testicle with 18 Gy., close followup and manage-ment of testicular cancer at an experienced center. In thefuture it will be surgically possible to resect even small tes-ticular tumors in the presence of a normal contralateraltestis without harming the patient. One must consider thatall patients will have testicular intraepithelial neoplasia inthe tumor bearing testicle that will proliferate if not treatedwith local radiation. However, local radiation has the poten-tial to damage the contralateral normal testis if no individ-ualized shielding is applied.

Dr. Hans Joachim Schmoll reviewed the manuscript.

REFERENCES

1. Bokemeyer, C., Schmoll, H. J., Schoffski, P. et al: Bilateraltesticular tumours: prevalence and clinical implications. Eur JCancer, 29: 874, 1993

2. Heidenreich, A. and Hofmann, R.: Quality-of-life issues in thetreatment of testicular cancer. World J Urol, 17: 230, 1999

3. Brunner, K. W.: Grundfragen der klinischen Onkologie anLebensqualitatsstudien. Akt Onkol, 63: 54, 1991

4. Heidenreich, A., Bonfig, R., Derschum, W. et al: A conservativeapproach to bilateral testicular germ cell tumors. J Urol, 153:10, 1995

5. Weissbach, L.: Organ preserving surgery of malignant germ celltumors. J Urol, 153: 90, 1995

6. Heidenreich, A., Holtl, W., Albrecht, W. et al: Testis-preservingsurgery in bilateral testicular germ cell tumors. Br J Urol, 79:253, 1997

7. Houlgatte, A., De La Taille, A., Fournier, R. et al: Paternity in apatient with seminoma and carcinoma in situ in a solitarytestis treated by partial orchiectomy. BJU Int, 84: 374, 1999

8. Kazem, I. and Danella, J. F.: Organ preservation for the treat-ment of contralateral testicular seminoma. Radiother Oncol,53: 45, 1999

9. Sawyer, E. J., Oliver, R. T., Tobias, J. S. et al: A lesson in themanagement of testicular cancer in a patient with a solitarytestis. Postgrad Med J, 75: 481, 1999

10. Fuse, H., Shimazaki, J. and Katayama, T.: Ultrasonography oftesticular tumors. Eur Urol, 17: 273, 1990

11. Menzner, A., Kujat, C., Konig, J. et al: MRI in testicular diag-nosis: differentiation of seminoma, teratoma and inflamma-tion using a statistical score. Rofo Fortschr Geb RontgenstrNeuen Bildgeb Verfahr, 166: 514, 1997

12. Lee, L. M., Johnson, H. W. and McLoughlin, M. G.: Microdissec-tion and radiographic studies of the arterial vasculature of thehuman testes. J Pediatr Surg, 19: 297, 1984

13. Jarow, J. P.: Intratesticular arterial anatomy. J Androl, 11: 255,1990

14. Middleton, W. D. and Bell, M. W.: Analysis of intratesticulararterial anatomy with emphasis on transmediastinal arteries.Radiology, 189: 157, 1993

15. Miller, D. C., Peron, S. E., Keck, R. W. et al: Effects of hypother-mia on testicular ischemia. J Urol, 143: 1046, 1990

16. Giwercman, A., von der Maase, H., Berthelsen, J. G. et al:

Localized irradiation of testes with carcinoma-in-situ: effect onLeydig cell function and eradication of malignant germ cells in20 patients. J Clin Endocrinol Metab, 73: 596, 1991

17. Buckspan, M. B., Klotz, P. G., Goldfinger, M. et al: Intraopera-tive ultrasound in the conservative resection of testicular neo-plasms. J Urol, 141: 326, 1989

18. Dieckmann, K. P. and Skakkebaek, N. E.: Carcinoma in situ ofthe testis: review of biological and clinical features. Int JCancer, 83: 815, 1999

19. von der Maase, H., Rorth, M. and Walbom-Jorgensen, S.: Carci-noma in situ of the contralateral testis in patients with testic-ular germ cell cancer. Br Med J, 293: 1398, 1986

20. Kliesch, S., Bergmann, M., Hertle, L. et al: Semen parametersand testicular pathology in men with testicular cancer andcontralateral carcinoma in situ or bilateral testicular malig-nancies. Hum Reprod, 12: 2830, 1997

21. Heidenreich, A., Vorreuther, R., Neubauer, S. et al: Paternity inpatients with bilateral testicular germ cell tumors. Eur Urol,31: 246, 1997

22. Behre, K. M., Kliesch, S., Leifke, E. et al: Long-term effect oftestosterone therapy on bone mineral density in hypogonadalmen. J Clin Endocrinol Metab, 82: 2386, 1997

23. Leifke, E., Korner, H. C., Link, T. M. et al: Effects of testosteronereplacement therapy on cortical and trabecular bone mineraldensity, vertebral body area and paraspinal muscle area inhypogonadal men. Eur J Endocrinol, 138: 51, 1998

EDITORIAL COMMENT

This series on organ sparing surgery in patients with metachro-nous or synchronous bilateral testicular tumors from the GermanTesticular Cancer Study Group is important. The major benefit ofsuch an approach is that 85% of patients in the long term did notneed testosterone replacement after partial orchiectomy and irradi-ation. This effect is a reasonable approach in patients with secondtesticular primaries who do not want to be fertile. This and otherstudies have shown that if only partial orchiectomy is performed andpostoperative radiation not given the probability of a local recurrenceis relatively high. Therefore, most would recommend postoperativeirradiation, which eliminates spermatogenesis.

Because 60% of these tumors were seminomas and irradiation isrequired postoperatively to minimize local recurrence, an intriguingquestion is whether or not up front irradiation could yield similarresults, with partial orchiectomy reserved for only those cases thatdid not respond completely to irradiation. Although an interestingbiological question, it likely has little clinical relevance since theresults of the approach described in this paper appear to be good inregard to long-term outcome, minimization of local recurrence andpreservation of normal testosterone levels in 85% of cases. Therefore,we have learned from this well documented study that partial orchi-ectomy is feasible in select patients, postoperative radiotherapy isnecessary to minimize local recurrence and 85% will have normaltestosterone levels in the long term.

Richard S. FosterDepartment of UrologyIndiana University Medical CenterIndianapolis, Indiana

ORGAN SPARING SURGERY FOR TESTICULAR CANCER 2165

Recommended